Filing Details

Accession Number:
0001209191-15-043709
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-05-18 16:02:22
Reporting Period:
2015-05-18
Filing Date:
2015-05-18
Accepted Time:
2015-05-18 16:02:22
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1516479 Insys Therapeutics Inc. INSY Pharmaceutical Preparations (2834) 510327886
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1044831 S Darryl Baker 444 South Ellis Street
Chandler AZ 85224
Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2015-05-18 6,000 $59.40 13,377 No 4 S Direct
Common Stock Disposition 2015-05-18 4,000 $58.83 9,377 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan
  2. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $59.21 to $59.62 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  3. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $58.25 to $59.17 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.